TMO vs CVS
By Alex · Tickerpine
Thermo Fisher Scientific Inc. vs CVS Health Corporation, side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | TMO | CVS |
|---|---|---|
| Price | $675.00 | $89.13 |
| Market cap | $249.58B | $113.99B |
| P/E ratio | 36.4 | 23.5 |
| ROE | 13.51% | 6.21% |
| Profit margin | 15.04% | 1.18% |
| Revenue growth | 10.50% | 7.10% |
| Dividend yield | 0.28% | 2.98% |
| Beta | 0.85 | 0.58 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
TMO vs CVS in plain English
- TMO is the bigger company — about 2.2× the market cap of CVS.
- CVS is cheaper on earnings (P/E 23.5 vs 36.4).
- TMO earns a higher return on equity (14% vs 6%).
- TMO is growing revenue faster (10% vs 7%).
- CVS has the higher dividend yield (2.98% vs 0.28%).
How would $1,000 have done in each?
TMO return calculator
See what $1,000 in Thermo Fisher Scientific Inc. would be worth today.
CVS return calculator
See what $1,000 in CVS Health Corporation would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.